HUMA
Humacyte Inc
0.5215$
+3.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -176.6% | – | – | – | -367.7% | -5,532.1% | -8,775.1% | -3,174.5% | -5,594.0% | -5,071.5% | -5,433.7% | -4,582.4% | |
| – | 17.0% | – | – | – | -4.5% | 354.4% | 617.9% | 247.7% | 287.2% | 361.6% | 550.2% | 340.9% | |
| – | 13.0% | – | – | – | 23.4% | 481.0% | 775.7% | 326.8% | 528.9% | 640.4% | 642.4% | 504.9% | |
| – | 29.0% | – | – | – | -38.9% | -1,849.9% | -464.5% | -547.3% | -1,779.9% | -263.6% | 315.8% | -587.3% | |
| – | 1.4% | – | – | – | 0.9% | 44.1% | 188.7% | 6.5% | 8.4% | 35.4% | 25.6% | 17.3% | |
| – | -1.4% | – | – | – | -0.9% | -44.1% | -188.7% | -6.5% | -8.4% | -35.4% | -25.6% | -17.3% | |
| – | – | – | – | – | – | – | – | – | 0.0% | – | – | – | |
| – | – | – | – | – | 9.8% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -9.3% | -132.9% | -241.5% | -98.7% | 8,391.0% | 0.0% | -42.9% | 1,804.3% | |
| – | -3.1% | – | – | – | 705.7% | 9,040.4% | 719.6% | -5,921.8% | 12,242.4% | 4,711.3% | 13,184.5% | 4,216.5% | |
| – | -181.1% | – | – | – | 337.1% | 3,464.2% | -8,292.0% | -9,102.8% | 6,640.0% | -395.6% | 7,725.1% | -383.3% | |
| – | -178.0% | – | – | – | -368.6% | -5,576.2% | -8,963.8% | -3,181.0% | -5,602.4% | -5,106.9% | -5,459.4% | -4,599.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.